JNJ

168.27

-0.78%↓

NVS

117.59

+0.37%↑

ABT

126.59

+0.73%↑

MDT

92.9

+0.6%↑

ELV.US

289.29

+3.16%↑

JNJ

168.27

-0.78%↓

NVS

117.59

+0.37%↑

ABT

126.59

+0.73%↑

MDT

92.9

+0.6%↑

ELV.US

289.29

+3.16%↑

JNJ

168.27

-0.78%↓

NVS

117.59

+0.37%↑

ABT

126.59

+0.73%↑

MDT

92.9

+0.6%↑

ELV.US

289.29

+3.16%↑

JNJ

168.27

-0.78%↓

NVS

117.59

+0.37%↑

ABT

126.59

+0.73%↑

MDT

92.9

+0.6%↑

ELV.US

289.29

+3.16%↑

JNJ

168.27

-0.78%↓

NVS

117.59

+0.37%↑

ABT

126.59

+0.73%↑

MDT

92.9

+0.6%↑

ELV.US

289.29

+3.16%↑

Search

Verastem Inc

Closed

6.12 15.25

Overview

Share price change

24h

Current

Min

5.96

Max

6.18

Key metrics

By Trading Economics

Income

12M

-52M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+148.37% upside

Dividends

By Dow Jones

Next Earnings

6 sie 2025

Verastem Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

8 maj 2025, 19:14 UTC

Major Market Movers

Verastem Ovarian-Cancer Drug Combination Gets FDA Approval -- Update

31 gru 2024, 19:15 UTC

Major Market Movers

Verastem Shares Soar on FDA Priority Review of Cancer Treatment

Peer Comparison

Price change

Verastem Inc Forecast

Price Target

By TipRanks

148.37% upside

12 Months Forecast

Average 15.25 USD  148.37%

High 20 USD

Low 12 USD

Based on 9 Wall Street analysts offering 12 month price targets forVerastem Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

9 ratings

9

Buy

0

Hold

0

Sell

Financials

Selling and administration expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Verastem Inc

There is no Profile data available for 2VS.SG.